What’s new
New biomarkers are needed in the prognosis and treatment process of the
disease. So far, there are no reports of IMA levels in patients with
pulmonary tuberculosis. To the best of our knowledge, this is the first
study to investigate IMA levels in patients with pulmonary tuberculosis.
For this purpose, it will be important to determine IMA levels in
diseases in which oxidative stress plays an important role in the
pathogenesis.